B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new 'Living Drug' to fight aggressive lymphoma
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called TranspoCART19 for adults with B-cell lymphoma that has come back or hasn't responded to standard treatments. Doctors will modify a patient's own immune cells to better target and fight their cancer, then infuse …
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Living Drug' trial offers hope for patients with aggressive blood cancers
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of a new type of personalized cell therapy called MB-CART19.1. It is for adults and children (ages 2-70) with certain B-cell blood cancers that have come back or have not responded to standard treatments. Doctors will col…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC